Featured Discovery

Home > Featured Discovery > Academician Chen Saijuan Published Latest Research on COVID-19 Treatment

Academician Chen Saijuan Published Latest Research on COVID-19 Treatment

September 18, 2020      Author: Yuan Jie

In order to confirm whether antibodies can exist in human body for a long time after COVID-19 infection, the National Translational Medicine Center of Ruijin Hospital affiliated to SJTU School of Medicine cooperated with Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, Shanghai Public Health Clinical Center and National Institutes for Food and Drug Control and conducted a long-term monitoring over COVID-19 infected patients. The results show that the protective neutralizing antibody still exists stably in human body 6 months after COVID-19 infection. The researchers also analyzed the existence of memory T cells targeting COVID-19 virus in the blood of recovered patients after 6-7 months of infection and found that CD4 and CD8 T cells responding to COVID-19 antigen existed in all tested samples.

The research was published in Frontiers of Medicine recently. The co-first authors are Dr. Tan Yun, Dr. Liu Feng and Dr. Xu Xiaoguang from National Translational Medicine Center of Ruijin Hospital affiliated to SJTU School of Medicine, Shanghai Institute of Hematology and State Key Laboratory of Medical Genomics; Dr. Ling Yun and Dr. Guo Mingquan from Shanghai Public Health Clinical Center; and researcher Huang Weijin from National Institutes for Food and Drug Control. The co-corresponding authors are Academician Chen Saijuan from National Translational Medicine Center of Ruijin Hospital affiliated to SJTU School of Medicine, Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics; and Professor Lu Hongzhou from Shanghai Public Health Clinical Center.

 

Translated by Zhou Rong  Reviewed by Wang Bingyu